Redcare Pharmacy NV (ETR:RDC)
77.90
-0.55 (-0.70%)
Oct 23, 2026, 5:35 PM CEST
Redcare Pharmacy NV Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Redcare Pharmacy NV stock has a consensus rating of "Buy" and an average price target of €88.80. The average 1-year stock price forecast is 13.99% higher than the current stock price, while the lowest is €55.00 (-29.40%) and the highest is €120.00 (+54.04%).
Price Target: €88.80 (+13.99%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Redcare Pharmacy NV stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Berenberg Bank | Berenberg Bank | Buy Maintains €94.00 → €102.00 | Buy | Maintains | €94.00 → €102.00 | +30.94% | Oct 7, 2026 |
| Baader Bank | Baader Bank | Buy Maintains €85.00 | Buy | Maintains | €85.00 | +9.11% | Oct 5, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains €110.00 → €114.00 | Buy | Maintains | €110.00 → €114.00 | +46.34% | Sep 30, 2026 |
| Deutsche Bank | Deutsche Bank | Buy Maintains €103.00 → €104.00 | Buy | Maintains | €103.00 → €104.00 | +33.50% | Sep 29, 2026 |
| Jefferies | Jefferies | Buy Maintains €97.00 | Buy | Maintains | €97.00 | +24.52% | Sep 28, 2026 |
Financial Forecast
Revenue This Year
3.45B
from 2.94B
Increased by 17.37%
Revenue Next Year
3.86B
from 3.45B
Increased by 11.70%
EPS This Year
-0.35
from -1.40
EPS Next Year
1.46
from -0.35
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.